Skip to main content
Log in

Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI: preliminary results

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

In order to establish the most reliable marker for distinguishing urinary tract infections (UTI) with and without renal parenchymal involvement (RPI), we recorded the clinical features and admission leukocyte count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum procalcitonin (PCT) in 57 children (including 43 girls) aged 2–108 months admitted with a first episode of UTI. RPI was evaluated by Tc-99m dimercaptosuccinic acid (DMSA) scintigraphy within 7 days of admission. To establish cut-off points for ESR, CRP, and PCT, we used receiver operating characteristics curves and compared the area under the curve for ESR, CRP, and PCT. Twenty-seven children were diagnosed as having RPI based on positive renal scintigraphy. A body temperature of >38°C, a history of diarrhea, and poor oral intake were more common in patients with RPI. ESR, CRP, and PCT, but not leukocyte count, were significantly higher in patients with RPI (P < 0.001). PCT was more sensitive and specific for the diagnosis of upper versus lower UTI than ESR and CRP. Using a cut-off value of 0.85 ng/ml, PCT had the best performance, with sensitivity, specificity, and positive and negative predictive values of 89%, 97%, 96%, and 91% respectively. Serum PCT is a better marker than ESR, CRP, and leukocyte count for the early prediction of RPI in children with a first episode of UTI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D (1993) Prevalence of urinary tract infection in febrile infants. J Pediatr 123:17–23. doi:10.1016/S0022-3476(05)81531-8

    Article  PubMed  CAS  Google Scholar 

  2. Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS (1998) Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 102:e16–e20. doi:10.1542/peds.102.2.e16

    Article  PubMed  CAS  Google Scholar 

  3. Hoberman A, Wald ER (1997) Urinary tract infections in young febrile children. Pediatr Infect Dis J 16:11–17. doi:10.1097/00006454-199701000-00004

    Article  PubMed  CAS  Google Scholar 

  4. Lin KY, Chiu NT, Chen MJ, Lai CH, Huang JJ, Wang YT et al (2003) Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol 18:362–365

    PubMed  Google Scholar 

  5. Jakobsson B, Berg U, Svensson L (1994) Renal scarring after acute pyelonephritis. Arch Dis Child 70:111–115

    Article  PubMed  CAS  Google Scholar 

  6. Lavocat MP, Granjon D, Allard D, Gay C, Freycon MT, Dubois F (1997) Imaging of pyelonephritis. Pediatr Radiol 27:159–165. doi:10.1007/s002470050091

    Article  PubMed  CAS  Google Scholar 

  7. Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4:620–630. doi:10.1016/S1473-3099(04)01146-6

    Article  PubMed  Google Scholar 

  8. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA (1999) Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count. Arch Dis Child 81:417–421

    Article  PubMed  CAS  Google Scholar 

  9. Pecile P, Romanello C (2007) Procalcitonin and pyelonephritis in children. Curr Opin Infect Dis 20:83–87. doi:10.1097/QCO.0b013e328013cb2a

    Article  PubMed  CAS  Google Scholar 

  10. Gervaix A, Galetto-Lacour A, Gueron T, Vadas L, Zamora S, Suter S et al (2001) Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J 20:507–511. doi:10.1097/00006454-200105000-00007

    PubMed  CAS  Google Scholar 

  11. Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacomuzzi F et al (2004) Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 114:e249–e254. doi:10.1542/peds.114.2.e249

    Article  PubMed  Google Scholar 

  12. Benador N, Siegrist CA, Gendrel D, Greder C, Benador D, Assicot M et al (1998) Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 102:1422–1425. doi:10.1542/peds.102.6.1422

    Article  PubMed  CAS  Google Scholar 

  13. Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R (2002) Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatr Nephrol 17:409–412. doi:10.1007/s00467-001-0790-1

    Article  PubMed  Google Scholar 

  14. Prat C, Dominguez J, Rodrigo C, Gimenez M, Azuara M, Jimenez O et al (2003) Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J 22:438–442. doi:10.1097/00006454-200305000-00010

    Article  PubMed  Google Scholar 

  15. Gűrgöze MK, Akarsu S, Yilmaz E, Godekmerdan A, Akca Z, Ciftsi I et al (2005) Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 20:1445–1448. doi:10.1007/s00467-005-1941-6

    Article  PubMed  Google Scholar 

  16. Bigot S, Leblond P, Foucher C, Hue V, D’Herbomez M, Foulard M (2005) Usefulness of procalcitonin for the diagnosis of acute pyelonephritis in children. Arch Pediatr 12:1075–1080. doi:10.1016/j.arcped.2005.03.058

    Article  PubMed  CAS  Google Scholar 

  17. Tuerlinckx D, Vander Borght T, Glupczynski Y, Galanti L, Roelants V, Krug B et al (2005) Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr 164:651–652. doi:10.1007/s00431-005-1700-5

    Article  PubMed  Google Scholar 

  18. Guven AG, Kazdal HZ, Koyun M, Aydn F, Gungor F, Akman S et al (2006) Accurate diagnosis of acute pyelonephritis: how helpful is procalcitonin? Nucl Med Commun 27:715–721. doi:10.1097/01.mnm.0000230072.61941.71

    Article  PubMed  CAS  Google Scholar 

  19. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Urinary Tract Infection (1999) Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and children. Pediatrics 103:843–852

    Google Scholar 

  20. Repetto HA, Alarcon PA, Pellegrini M (2003) Procalcitonin as a marker of acute pyelonephritis. Pediatr Nephrol 18:726

    PubMed  CAS  Google Scholar 

  21. Ataei N, Madani A, Habibi R, Khorasani M (2005) Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years. Pediatr Nephrol 20:1439–1444. doi:10.1007/s00467-005-1925-6

    Article  PubMed  Google Scholar 

  22. Wang YT, Chiu NT, Chen MJ, Huang JJ, Chou HH, Chiou YY (2005) Correlation of renal ultrasonographic findings with inflammatory volume from dimercaptosuccinic acid renal scans in children with acute pyelonephritis. J Urol 173:190–194

    PubMed  Google Scholar 

  23. Temiz Y, Tarcan T, Onol FF, Alpay H, Simşek F (2006) The efficacy of Tc-99m dimercaptosuccinic acid (Tc-DMSA) scintigraphy and ultrasonography in detecting renal scars in children with primary vesicoureteral reflux (VUR). Int Urol Nephrol 38:149–152. doi:10.1007/s11255-005-3829-6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefanos Gardikis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kotoula, A., Gardikis, S., Tsalkidis, A. et al. Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI: preliminary results. Int Urol Nephrol 41, 393–399 (2009). https://doi.org/10.1007/s11255-008-9472-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9472-2

Keywords

Navigation